Moldovan Journal of Health Sciences,
Journal Year:
2023,
Volume and Issue:
4, P. 54 - 67
Published: Dec. 1, 2023
Introduction.
In
the
last
years
high
prevalence
of
tic
disorder
and
Gilles
de
la
Tourette
syndrome
(GTS)
was
confirmed.
The
available
therapies
can
temporarily
suppress
tics,
but
not
eliminate
them
definitively,
that
implies
a
strict
individual
assessment
risks
benefits
for
every
patient.
recent
scientific
studies
confirmed
efficiency
some
diagnostic
therapeutic
options,
infirmed
other
ones.
Thus,
qualitative
analysis
adjustment
recommendations
to
actual
conditions
possibilities
Republic
Moldova
(RM)
is
required.
Material
methods.
All
guidelines
diagnosis
treatment
GTS
disorders
were
found
in
PubMed
database.
articles
containing
keywords
„Tourette
diagnosis“,
treatment“,
„tic
diagnosis“
or
treatment“
published
after
2021
selected.
availability
RM
medications
recommended
by
international
verified
on
site
Medicines
Medical
Devices
Agency
RM.
final
text
includes
synthesis
recommendations,
adapted
Results.
tics
needs
only
clinical
observation,
usually
investigations
are
indicated.
It
extremely
important
identify
patients
whose
do
need
treatment,
just
monitoring
informing
about
their
nature.
There
three
main
methods
directed
against
tics:
behavioural
therapy,
pharmacotherapy,
and,
particular
cases,
neurosurgical
approach
(deep
brain
stimulation).
first
two
had
been
yet.
A
attention
paid
management
specific
comorbidities
tics.
Conclusions.
based
recognition
manifestations
precise
anamnesis.
Only
with
all
should
be
informed
tics’
nature,
causes
evolution.
therapy
could
effective
patients,
while
others
would
more
convenient
pharmacotherapy
combination
both.
stimulation)
reserved
severe
resistant
therapies.
Annals of Medicine and Surgery,
Journal Year:
2025,
Volume and Issue:
87(4), P. 2163 - 2179
Published: Feb. 27, 2025
Introduction:
Deep
brain
stimulation
(DBS)
has
emerged
as
a
promising
therapeutic
approach,
offering
targeted
neuromodulation
for
movement
disorders
refractory
to
medical
management
or
stereotactic
surgery.
However,
assessing
its
benefits
against
potential
risks
is
essential.
This
meta-analysis
aims
evaluate
the
efficacy
and
safety
of
DBS
in
disorders,
shedding
light
on
role
an
alternative
option.
Methods:
A
comprehensive
search
databases
after
systemic
review
yielded
studies
published
English
from
2000
present.
Data
selection,
screening,
extraction,
risk
bias
assessment
were
performed
meticulously.
Statistical
analysis
was
conducted
using
RevMan
2.0,
with
significant
heterogeneity
addressed
through
appropriate
methods.
Results:
Our
included
40
Unified
Parkinson’s
Disease
Rating
Scale
Part
III,
revealing
improvement
motor
symptoms
(mean
difference
[MD]:
−18.05,
95%
confidence
interval
[CI]
[−20.17,
−15.93],
P
<
0.00001).
Hoehn
Yahr
Stage
demonstrated
reduction
disease
severity
(MD:
−0.58,
CI
[−1.05,
−0.12],
=
0.01).
Tremor
−8.22,
[−12.30,
−4.15],
0.0001),
overall
tremor
−2.68,
[−4.59,
−0.77],
0.006),
gait
velocity
0.13,
[0.08,
0.18],
0.00001),
Yale
Global
Tic
Severity
score
−9.75,
[−14.55,
−4.96],
0.0001)
also
showed
improvements
DBS.
Conclusion:
demonstrates
improving
symptoms,
severity,
tremor,
gait,
tic
disorders.
further
research
needed
elucidate
long-term
outcomes.
Science Advances,
Journal Year:
2025,
Volume and Issue:
11(13)
Published: March 28, 2025
Tourette’s
syndrome
(TS)
is
a
major
neurodevelopmental
disorder
characterized
by
childhood-onset
motor
and
vocal
tics.
A
W88C
mutation
in
WWC1
gene
notable
risk
factor
for
TS,
but
the
underlying
molecular
mechanisms
remain
unclear
due
to
lack
of
suitable
animal
models.
Here,
we
generate
mutant
mouse
line
with
human
(W88C
Mut
mice),
which
exhibits
behavioral
deficits
similar
those
observed
patients
including
repetitive
behaviors
sensorimotor
gating
abnormalities.
The
leads
degradation
kidney
brain
(KIBRA)
protein
via
proteasomal
pathway,
evokes
dopamine
release
dorsal
striatum,
disrupts
synaptic
function
through
dysregulation
Hippo
pathway.
Neuron-specific
overexpression
wild-type
rescues
phenotypes
mice.
Together,
this
study
not
only
provides
valuable
model
studying
TS
also
offers
fresh
insights
into
abnormalities
TS.
Frontiers in Pediatrics,
Journal Year:
2025,
Volume and Issue:
13
Published: May 20, 2025
Tic
disorders
(TD)
represent
a
prevalent
neurodevelopmental
condition
in
children,
characterised
by
involuntary,
sudden
motor
or
vocal
tics.
Dysfunction
of
the
dopamine
system
plays
pivotal
role
pathogenesis
TD.
Recent
findings
indicate
that
deep
brain
stimulation,
modulating
striatal
release,
substantially
alleviates
tic
symptoms.
Neuroimaging
studies
have
shown
increased
transporter
binding
and
decreased
serotonin
levels
patients
with
The
presence
anti-dopamine
D2
receptor
autoantibodies,
which
correlate
disease
severity,
suggests
immune
involvement
onset
Nutritional
factors
influence
dopaminergic
system's
functionality
affecting
neurotransmitter
synthesis
metabolism,
gut
microbiota
contributing
to
neuroinflammation.
Clinical
demonstrated
interventions
combining
probiotics
fructooligosaccharides
can
help
regulate
whereas
dietary
patterns
such
as
ketogenic,
Mediterranean
Mediterranean-DASH
intervention
for
neurodegenerative
delay
diets
exhibit
anti-inflammatory
neuroprotective
effects.
risk
TD
offspring
is
significantly
associated
maternal
autoimmune
diseases
inflammatory
states,
metabolic
syndrome
further
via
AT1
autoantibodies.
intervention-based
treatment
strategies
present
promising
directions
management,
warranting
investigation
into
nutrition–immune–neurotransmitter
network,
development
personalised
nutritional
plans
validation
their
clinical
efficacy
through
large-scale
randomised
controlled
trials.
This
review
summarises
alterations
TD,
regulatory
effects
on
levels,
interactions
between
neuroinflammation
based
interventions,
laying
theoretical
foundation
understanding
advancing
novel
therapeutic
approaches.
World Journal of Psychiatry,
Journal Year:
2024,
Volume and Issue:
14(7), P. 999 - 1008
Published: July 11, 2024
Cognitive-behavioral
therapy
(CBT)
and
habit
reversal
training
(HRT)
have
shown
application
potential
in
addressing
tic
symptoms
comorbid
psychiatric
conditions.
Despite
their
theoretical
potential,
empirical
evidence
on
combined
efficacy
remains
limited.
Annals of Neurology,
Journal Year:
2023,
Volume and Issue:
95(1), P. 174 - 189
Published: Sept. 30, 2023
The
SLIT
and
NTRK-like
1
(SLITRK1)
gene
mutation
striatal
cholinergic
interneurons
(ChIs)
loss
are
associated
with
Tourette
syndrome
(TS).
ChIs
comprise
only
to
2%
of
neurons
but
project
widely
throughout
the
stratum
impact
various
neurotransmission,
including
TS-related
dopaminergic
transmission.
Here,
we
link
Slitrk1,
ChI
function,
transmission
their
associations
TS-like
tic
behaviors.Slitrk1-KD
mice
were
induced
by
bilaterally
injecting
Slitrk1
siRNA
into
dorsal
striatum.
Control
received
scrambled
injection.
Their
behaviors,
prepulse
inhibition,
sensory-motor
function
dopamine-related
behaviors
compared.
We
also
compared
dopamine
ACh
levels
in
microdialysates,
Slitrk
protein
transporter
levels,
numbers
Slitrk-positive
activated
striatum
between
two
mouse
groups,
electrophysiological
properties
Slitrk-negative
ChIs.Slitrk1-KD
exhibit
haloperidol-sensitive
stereotypic
impaired
delayed
sensorimotor
response
control
group.
These
characteristics
correlate
lower
fewer
Slitrk1-containing
ChIs,
Slitrk1-KD
mice.
Based
on
properties,
Slitrk1-negative
less
excitable
than
Slitrk1-positive
ChIs.
have
evoked
acetylcholine
higher
tonic
downregulated
transporters
striatum,
increased
apomorphine-induced
climbing
methamphetamine-induced
hyperlocomotion
controls.Slitrk1
is
pivotal
maintaining
activity
subsequent
for
normal
motor
functioning.
Furthermore,
conditional
may
serve
as
a
translational
modality
aspects
TS
phenomenology.
ANN
NEUROL
2023.
Tremor and Other Hyperkinetic Movements,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Jan. 1, 2024
Background:
Tourette
syndrome
(TS)
is
a
neurologic
condition
characterized
by
motor
and
phonic
tics.Dystonic
tics,
including
blepharospasm,
are
considered
atypical
or
unusual
in
severe
TS.
Case
Report:We
report
case
of
TS
with
facial
dystonic
tics
resembling
blepharospasm
which
the
microlesion
effect
sustained
therapeutic
was
observed
bilateral
globus
pallidus
interna
(GPi)
deep
brain
stimulation
(DBS).Discussion:
Bilateral
GPi
DBS
can
be
beneficial
for
blepharospasm-like
symptoms
TS.The
improvements
seen
explained
induced
lead
placement
GPi.
Molecular Psychiatry,
Journal Year:
2024,
Volume and Issue:
29(10), P. 3076 - 3085
Published: April 25, 2024
With
advances
in
our
understanding
regarding
the
neurochemical
underpinnings
of
neurological
and
psychiatric
diseases,
there
is
an
increased
demand
for
advanced
computational
methods
analysis.
Despite
having
a
variety
techniques
measuring
tonic
extracellular
concentrations
neurotransmitters,
including
voltammetry,
enzyme-based
sensors,
amperometry,
vivo
microdialysis,
currently
no
means
to
resolve
structurally
similar
neurotransmitters
from
mixtures
environment
with
high
spatiotemporal
resolution
limited
tissue
damage.
Since
research
clinical
investigations
involve
brain
regions
containing
electrochemically
monoamines,
such
as
dopamine
norepinephrine,
developing
model
respective
contributions
these
vital
importance.
Here
we
have
developed
deep
learning
network,
DiscrimNet,
convolutional
autoencoder
capable
accurately
predicting
individual
dopamine,
serotonin
both
vitro
anesthetized
rats,
measured
using
voltammetry.
The
architecture
DiscrimNet
described,
its
ability
predict
unseen
shown
vastly
outperform
shallow
algorithms
previously
used
neurotransmitter
discrimination.
generalize
well
data
captured
electrodes
during
training,
eliminating
need
retrain
each
new
electrode.
also
expected
changes
after
cocaine
oxycodone
administration
rats
vivo.
therefore
offers
exciting
method
real-time
voltammetric
signals
into
component
neurotransmitters.